Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC

V. Koucký, K. Hladíková, E. Táborská, J. Bouček, M. Grega, R. Špíšek, A. Fialová

. 2021 ; 70 (9) : 2545-2557. [pub] 20210211

Language English Country Germany

Document type Journal Article

Grant support
668217 Grantová Agentura, Univerzita Karlova

E-resources Online Full text

NLK PubMed Central from 1982
ProQuest Central from 1997-03-01 to 1 year ago
Medline Complete (EBSCOhost) from 2000-04-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-03-01 to 1 year ago
Public Health Database (ProQuest) from 1997-03-01 to 1 year ago

Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024994
003      
CZ-PrNML
005      
20220929144812.0
007      
ta
008      
211013s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00262-021-02874-y $2 doi
035    __
$a (PubMed)33569630
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Koucký, Vladimír $u , Sotio, Prague, Czech Republic. koucky@sotio.com $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic. koucky@sotio.com
245    14
$a The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC / $c V. Koucký, K. Hladíková, E. Táborská, J. Bouček, M. Grega, R. Špíšek, A. Fialová
520    9_
$a Plasmacytoid dendritic cells (pDCs) are the most potent type I interferon-producing cells and play an important role in antiviral immunity. Tumor-infiltrating pDCs were shown to be predominantly pro-tumorigenic, with reduced ability to produce interferon alpha (IFNα) and confirmed capacity to prime regulatory T cells (Tregs) by the ICOS/ICOS-L pathway. Because a significant number of HNSCCs are induced by human papillomaviruses and show markedly different immune profiles than non-virally induced tumors, we compared the phenotype and functional capacity of HNSCC-infiltrating pDCs to the HPV status of the tumor. We observed a reduced capacity of pDCs to produce IFNα upon toll-like receptor activation in HPV-negative samples and a rather uncompromised functionality in HPV-associated tumors. Additionally, supernatants from non-virally induced but not HPV-associated tumor cell suspensions significantly inhibited IFNα production by peripheral blood-derived pDCs. We identified IL-10 and TNFα as the soluble pDC-suppressive factors with the highest variability between HPV-negative and HPV-positive tumor-derived supernatants. Additionally, we observed a positive correlation of tumor-infiltrating pDCs with Tregs in HPV-negative samples but not in virally induced tumors. Overall, our study indicates that the immunosuppressive cytokine milieu rich in IL-10 and TNFα in HPV-negative but not in HPV-positive HNSCC significantly affects the functional capacity of tumor-infiltrating pDCs, and such dysfunctional pDCs may further support the immunosuppressive tumor microenvironment by promoting the expansion of Tregs in the tumor tissue.
650    _2
$a biologické markery $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a virová transformace buněk $7 D002472
650    _2
$a cytokiny $x metabolismus $7 D016207
650    _2
$a dendritické buňky $x imunologie $x metabolismus $x patologie $7 D003713
650    _2
$a náchylnost k nemoci $7 D004198
650    _2
$a exprese genu $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a interferon alfa $x imunologie $x metabolismus $7 D016898
650    _2
$a infekce papilomavirem $x komplikace $x virologie $7 D030361
650    _2
$a dlaždicobuněčné karcinomy hlavy a krku $x etiologie $x metabolismus $x patologie $7 D000077195
650    _2
$a T-lymfocyty - podskupiny $x imunologie $x metabolismus $7 D016176
650    _2
$a regulační T-lymfocyty $x imunologie $x metabolismus $7 D050378
650    12
$a nádorové mikroprostředí $x imunologie $7 D059016
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hladíková, Kamila $u , Sotio, Prague, Czech Republic
700    1_
$a Táborská, Eliška $u Sotio, Prague, Czech Republic $7 ola20211133478
700    1_
$a Bouček, Jan $u Department of Otorhinolaryngology and Head and Neck Surgery, First Medical Faculty, Motol University Hospital, Prague, Czech Republic
700    1_
$a Grega, Marek $u Department of Pathology and Molecular Medicine, Second Medical Faculty, Motol University Hospital, Prague, Czech Republic
700    1_
$a Špíšek, Radek $u , Sotio, Prague, Czech Republic
700    1_
$a Fialová, Anna $u , Sotio, Prague, Czech Republic. fialova@sotio.com
773    0_
$w MED00001041 $t Cancer immunology, immunotherapy : CII $x 1432-0851 $g Roč. 70, č. 9 (2021), s. 2545-2557
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33569630 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20220929144806 $b ABA008
999    __
$a ok $b bmc $g 1714163 $s 1145501
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c 9 $d 2545-2557 $e 20210211 $i 1432-0851 $m Cancer immunology and immunotherapy $n Cancer Immunol Immunother $x MED00001041
GRA    __
$a 668217 $p Grantová Agentura, Univerzita Karlova
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...